
Pascal Soriot
Vermogen: 66 M $ op 31-05-2026

Vermogen: 66 M $ op 31-05-2026
Momenteel is Pascal Soriot Chief Executive Officer & Executive Director bij AstraZeneca Plc en voorzitter van AstraZeneca AB (een dochteronderneming van AstraZeneca Plc). Hij zit ook in de raad van bestuur van Pharmaceutical Research & Manufacturers of America en Acerta Pharma BV. Pascal Soriot was voorheen Manager-District Sales bij Roussel NZ Ltd., Director & Chief Executive Officer-Roche Group bij Genentech, Inc., Chief Operating Officer bij Roche Pharmaceuticals, Inc., Chief Operating Officer bij Sanofi-Aventis U.S. LLC en Vice President-Asia Pacific bij Hoechst Marion Rousel JP. Hij behaalde een MBA aan de cole des Hautes tudes Commerciales de Paris en een doctoraat aan de cole Nationale Vtrinaire d'Alfort.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASTRAZENECA PLC 0,02% | 14-05-2026 | 355.461 ( 0,02% ) | 66 M $ | 31-05-2026 |
| 19-03-2026 | 2.683 ( 0% ) | 363 627 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ASTRAZENECA PLC | Algemeen Directeur | 01-10-2012 |
| AGILENT TECHNOLOGIES, INC. | Directeur/Bestuurslid | 20-05-2025 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Directeur/Bestuurslid | - |
AstraZeneca Colombia SAS | Algemeen Directeur | 01-10-2012 |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Algemeen Directeur | - |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Algemeen Directeur | - |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Algemeen Directeur | - |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Algemeen Directeur | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Bestuurslid | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░ | ░░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 21 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Agilent Technologies, Inc.
Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Hoechst Marion Rousel JP
Hoechst Marion Rousel JP Miscellaneous Commercial ServicesCommercial Services Conducts medical research | Commercial Services |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Health Technology |
AstraZeneca Colombia SAS | |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roussel NZ Ltd. | |
École Nationale Vétérinaire d'Alfort
École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Viela Bio, Inc.
Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
The Sustainable Markets Initiative |
Kies jouw editie
Alle financiële informatie op nationaal niveau